Sokoll LJ - Search Results

1

Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.

Naya Y, Fritsche HA, Cheli CD, Stamey TA, Bartsch G, Brawer MK, Childs S, Taneja SS, Lepor H, Partin AW, Sokoll LJ, Chan DW, Babaian RJ. Naya Y, et al. Among authors: sokoll lj. Urology. 2003 Dec;62(6):1058-62. doi: 10.1016/j.urology.2003.07.016. Urology. 2003. PMID: 14665355

2

Prostate-specific antigen. Its discovery and biochemical characteristics.

Sokoll LJ, Chan DW. Sokoll LJ, et al. Urol Clin North Am. 1997 May;24(2):253-9. doi: 10.1016/s0094-0143(05)70370-0. Urol Clin North Am. 1997. PMID: 9126221 Free article. Review.

3

Bone to total alkaline phosphatase ratios improve sensitivity and specificity of bone alkaline phosphatase immunoassays.

Sokoll LJ, Kroll MH, Levine MA, Poordad FF, Chan DW. Sokoll LJ, et al. Clin Biochem. 1997 Dec;30(8):625-9. doi: 10.1016/s0009-9120(97)00117-3. Clin Biochem. 1997. PMID: 9455616 Free article.

4

Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.

Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, Wolfert R, Carter HB. Epstein JI, et al. Among authors: sokoll lj. J Urol. 1998 Dec;160(6 Pt 2):2407-11. J Urol. 1998. PMID: 9817393 Free article. Review.

5

Critical analysis of false elevations in PSA results reported with the Abbott AxSYM assay.

Sokoll LJ, Partin AW, Nelson JB, Chan DW. Sokoll LJ, et al. Prostate. 1999 Jan 1;38(1):79-80. doi: 10.1002/(sici)1097-0045(19990101)38:1<79::aid-pros10>3.0.co;2-c. Prostate. 1999. PMID: 9973113 No abstract available.

6

Prostate-specific antigen: update 1997.

Chan DW, Sokoll LJ. Chan DW, et al. Among authors: sokoll lj. J Int Fed Clin Chem. 1997 Sep;9(3):120-5. J Int Fed Clin Chem. 1997. PMID: 10174623 Review.

7

Prostate-specific antigen: advances and challenges.

Chan DW, Sokoll LJ. Chan DW, et al. Among authors: sokoll lj. Clin Chem. 1999 Jun;45(6 Pt 1):755-6. Clin Chem. 1999. PMID: 10351982 No abstract available.

8

Clinical analyzers. Immunoassays.

Sokoll LJ, Chan DW. Sokoll LJ, et al. Anal Chem. 1999 Jun 15;71(12):356R-362R. doi: 10.1021/a1999910i. Anal Chem. 1999. PMID: 10384792 Review. No abstract available.

9

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.

Brawer MK, Cheli CD, Neaman IE, Goldblatt J, Smith C, Schwartz MK, Bruzek DJ, Morris DL, Sokoll LJ, Chan DW, Yeung KK, Partin AW, Allard WJ. Brawer MK, et al. Among authors: sokoll lj. J Urol. 2000 May;163(5):1476-80. J Urol. 2000. PMID: 10751861

10

Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays.

Vessella RL, Lange PH, Partin AW, Chan DW, Sokoll LJ, Sasse EA, Crawford ED. Vessella RL, et al. Among authors: sokoll lj. Urology. 2000 Jun;55(6):909-14. doi: 10.1016/s0090-4295(00)00461-1. Urology. 2000. PMID: 10840107 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters